Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

DOPAMINERGIC DRUGS vs placebo

Tardive dyskinesia: No clinically important improvement · patients with antipsychotic‐induced tardive dyskinesia

DOPAMINERGIC DRUGS may leads to lower tardive dyskinesia: No clinically important improvement compared with PLACEBO (low certainty).

1 finding from 1 review

Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.52 [0.29, 0.96]
1 study · 20 participants
Low

DOPAMINERGIC DRUGS vs other drugs

Tardive dyskinesia: No clinically important improvement · patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether DOPAMINERGIC DRUGS changes tardive dyskinesia: No clinically important improvement compared with OTHER DRUGS (very low certainty).

1 finding from 1 review

Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.93 [0.45, 1.95]
1 study · 13 participants
Very low